Oct 13 (Reuters) - WCG Clinical Inc, a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, on Wednesday filed to withdraw its initial public offering in the United States. (Reporting by Niket Nishant in Bengaluru; Editing by Shailesh Kuber)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- WCGC Stock
- News WCG Clinical, Inc.
- WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans